Substance Abuse and Drug Testing — All Questions

Ongoing voluntary attendance at self-help groups (e.g., 12-step programs) for maintenance of recovery from alcoholism __________.

Which of the following is a requirement for a driver with a history of alcoholism to be certified?

A driver taking multiple medications reports daily moderate use of alcohol. Which of the following statements about alcohol use and CMV driver qualification is correct?

When evaluating a driver who was previously disqualified for alcoholism, what may the medical examiner request to support recertification?

Which federal regulation specifically governs alcohol and drug use and testing requirements for CLP/CDL holders?

Which federal regulation specifically addresses the use of Schedule I controlled substances by CMV drivers?

Under FMCSA regulations, which of the following is TRUE regarding a driver who uses marijuana in a state where it is legal for recreational use?

A 52-year-old driver presents with a history of two DUI convictions, the most recent being 3 years ago. He reports no current alcohol use and attends AA meetings weekly. What is the most appropriate action?

Which of the following is a Schedule I controlled substance that would disqualify a CMV driver under 49 CFR 391.41(b)(12)?

During a DOT physical examination, which finding would be the strongest indicator of possible active alcohol abuse requiring further evaluation?

A CMV driver reports using CBD oil purchased from a health food store. How should the medical examiner address this?

A driver presents with a prescription for Adderall (amphetamine salts) for ADHD. Under FMCSA guidelines, how should the medical examiner proceed?

Under FMCSA regulations, which statement about medical marijuana use by CMV drivers is correct?

Naltrexone used for alcohol dependence maintenance therapy in a CMV driver should be evaluated by the medical examiner in what manner?

A 38-year-old CMV driver admits to using heroin one time recreationally six months ago but states he has been clean since. Urine drug screen is negative. What is the appropriate action?

Which type of DOT drug or alcohol test is NOT required by FMCSA regulations?

A CMV driver presents for a DOT physical and reports taking oxycodone prescribed by his physician for chronic back pain. What should the medical examiner do?

Under FMCSA regulations, which statement is TRUE regarding the use of over-the-counter medications by CMV drivers?

A 55-year-old driver has a documented history of alcohol dependence with 5 years of verified sobriety and active participation in Alcoholics Anonymous. What certification determination is most appropriate?

A driver presents to the medical examiner with track marks on both arms. The driver denies any drug use and has no prescriptions for injectable medications. What is the most appropriate action?

Which of the following best describes the FMCSA’s position on the use of Schedule I controlled substances by CMV drivers?

A 42-year-old driver reports completing a 28-day inpatient alcohol rehabilitation program 8 months ago. He has been sober since discharge and provides documentation from his aftercare program. What additional information would be most helpful for the certification decision?

A 48-year-old CMV driver discloses that he completed a cocaine treatment program 2 years ago and has been clean since, with monthly negative drug screens. What is the most appropriate certification approach?

Under FMCSA regulations, a medical examiner discovers that a CMV driver has been self-administering testosterone injections obtained from an overseas pharmacy without a prescription. What is the most appropriate action?

A CMV driver presents for a DOT physical and reports a single DUI arrest 2 years ago with no conviction. He reports no current alcohol use. What is the most appropriate approach?

What is the FMCSA’s guidance regarding drivers who have successfully completed the return-to-duty process and wish to obtain a new medical certificate?

A 50-year-old driver reports taking tramadol for chronic knee pain. Under current DEA scheduling, tramadol is classified as which schedule?

A CMV driver states he used marijuana 45 days ago but has stopped completely. He provides a negative urine drug screen from last week. Can the medical examiner certify this driver?

A 29-year-old driver admits to recreational use of LSD (lysergic acid diethylamide) within the past year. What is the appropriate certification action?

A medical examiner suspects a driver may be under the influence of alcohol during a DOT physical examination. What should the examiner do?

Under FMCSA regulations, which of the following statements about the relationship between state and federal drug laws is correct regarding CMV drivers?

A driver undergoing the DOT physical reports taking disulfiram (Antabuse) as prescribed for alcohol dependence. How does this medication affect the certification decision?

A 33-year-old CMV driver has a valid prescription for medical marijuana from a state-licensed physician for chronic pain. The driver’s employer operates exclusively within that state. Can the medical examiner certify this driver?

When a CMV driver presents for a DOT physical and reports a past history of substance abuse with successful treatment, what documentation should the medical examiner request?

Which statement best describes the legal status of synthetic cannabinoids (e.g., K2, Spice) for CMV drivers?

A 47-year-old CMV driver presents with a history of alcohol-related liver disease (elevated liver enzymes, previous diagnosis of alcoholic hepatitis). He reports 3 years of sobriety and provides AA attendance records. Liver enzymes are now mildly elevated. What is the most appropriate action?

A CMV driver reports occasional use of delta-8 THC products, which are marketed as legal hemp derivatives. How should the medical examiner evaluate this?

What minimum follow-up testing frequency must the SAP prescribe in the first 12 months after a driver returns to safety-sensitive duties?

A 44-year-old driver discloses that he regularly uses psilocybin mushrooms recreationally but states it does not affect his driving. How should the medical examiner respond?

What is the significance of CAGE questionnaire screening during a DOT physical examination?

A CMV driver presents with prescriptions for both hydrocodone and alprazolam. What is the primary concern with this medication combination?

Under DOT regulations, which of the following drivers is exempt from the DOT drug and alcohol testing requirements?

A 38-year-old CMV driver reports that he completed a court-ordered substance abuse treatment program after a DUI conviction 18 months ago. His current drug and alcohol screens are negative. What additional information is most important for the certification decision?

A CMV driver who is a recovering alcoholic presents with elevated GGT (gamma-glutamyl transferase) levels on lab work. What is the clinical significance for the DOT physical?

What is the medical examiner’s obligation if a CMV driver voluntarily discloses current use of an illicit substance during the DOT physical examination?

A CMV driver with a history of opioid use disorder has been on naltrexone (Vivitrol) injections monthly for the past 2 years with documented sobriety. What certification approach is most appropriate?

Under FMCSA regulations, what is the medical examiner’s role regarding DOT drug testing during the physical examination?

A 56-year-old CMV driver presents with a prescription for phenobarbital for seizure prevention. Setting aside the seizure disorder itself, what concern does phenobarbital raise regarding substance abuse screening?

A driver presents for a DOT physical and mentions that he takes an herbal sleep supplement containing valerian root and melatonin nightly. How should the medical examiner address this?

A 31-year-old driver recently completed the return-to-duty process after a positive marijuana test. During his next DOT physical, you notice dilated pupils and the driver appears anxious and distracted. What should you do?

Which of the following scenarios would NOT trigger a DOT post-accident drug and alcohol test?

What is the maximum total duration that a SAP can require follow-up testing after a driver returns to safety-sensitive duties?

A driver on your schedule today is taking acamprosate (Campral) for alcohol craving reduction. How does this medication affect the certification decision?

Under FMCSA regulations, which statement is correct regarding the use of amphetamines by CMV drivers?

A CMV driver was terminated from a previous employer after a positive DOT drug test. He completed the return-to-duty process and is now hired by a new employer. What obligation does the new employer have?

During a DOT physical, a driver reports drinking 2-3 beers every evening after work. He denies any work-related alcohol use. What is the most appropriate response by the medical examiner?

Which of the following most accurately describes the DOT Clearinghouse established in January 2020?

A 41-year-old CMV driver presents taking dronabinol (Marinol), a synthetic THC prescribed for severe nausea from chemotherapy. Can the driver be certified?

Medical marijuana use by a CMV driver is considered what under federal regulations?

What is the blood alcohol concentration threshold for CMV drivers?

Under what circumstances may an ME certify an individual who has a prior clinical diagnosis of alcoholism?

An individual with alcoholism in remission has developed permanent neurological changes due to past alcohol use. How should these be evaluated?

What information should the ME consider when determining whether an individual has a current clinical diagnosis of alcoholism?

DOT-regulated drug and alcohol testing under Part 382 applies to which group of commercial drivers?

The FMCSRs include a mandatory waiting time prior to medical certification after known or disclosed illegal drug use. True or false?

Signs of drug abuse that an ME should look for during the physical examination include which findings?

Schedule II drugs include which categories of substances?

When evaluating a driver treated with Suboxone, the ME must have information from which source before making a certification determination?

The ME suspects a driver has not disclosed use of a scheduled drug or substance. What action may the ME take?

A driver on Suboxone presents for certification with a letter from his prescribing physician. The ME notices signs of impaired alertness during the examination. What should guide the ME’s decision?

A driver being evaluated for alcoholism is found to have transient neurological changes from past alcohol use. How should the ME handle this?

A 45-year-old driver recovering from alcoholism has been sober for 18 months with documentation from a substance abuse counselor confirming remission. The ME notes mild bilateral peripheral neuropathy in the feet during the examination. How should the ME proceed?

What is the key distinction between Schedule I controlled substances and Schedule II through V controlled substances regarding CMV driver physical qualification?

Which three conditions must be satisfied for a Schedule II through V drug to meet the prescription exception under 49 CFR 391.41(b)(12)(ii)?

A 50-year-old CMV driver presents for physical qualification and discloses that he is currently prescribed methadone by his physician for chronic pain management. His prescriber has provided a letter confirming familiarity with the driver’s history and stating the medication will not impair safe CMV operation. What is the most appropriate action?

A driver undergoing physical qualification reports using a CBD oil product purchased online. The product label claims less than 0.3% THC. According to the handbook, how should the ME approach this situation?

A 35-year-old CMV driver is being treated with Suboxone (buprenorphine/naloxone) for opioid use disorder. His prescribing physician confirms stability and no adverse effects on driving ability. Which statement correctly reflects FMCSA guidance on this situation?

The controlled substance schedules (I through V) established by the DEA are based on which primary factors?

A CMV driver taking a Schedule IV sedative reports feeling drowsy during early morning shifts, occasionally missing doses due to irregular work hours, and needing higher doses on days with heavy physical demands. Which factor is most directly relevant to the ME’s certification concern?

An ME is evaluating a driver who admits to occasional recreational marijuana use. The driver lives in a state where recreational marijuana is legal. The driver argues this should not affect his certification. What is the correct regulatory position?

A 40-year-old driver with a history of opioid use disorder has been sober for 3 years and is currently taking Suboxone. His prescriber confirms stability. During the physical exam, the ME notices the driver has slow reaction time and mild sedation. What should guide the ME’s final certification decision?

A 55-year-old driver is prescribed morphine (Schedule II) for chronic pain and also takes lorazepam (Schedule IV) for anxiety. Both prescribers have provided letters meeting the prescription exception requirements. Which of the following considerations is MOST important for the ME when evaluating this driver’s fitness?

The phrase ‘current clinical diagnosis of alcoholism’ in 49 CFR 391.41(b)(13) is specifically designed to encompass which of the following?

Under 49 CFR 391.41(b)(12), what three conditions must the prescribing practitioner meet for a Schedule II through V drug to satisfy the prescription exception?

A 48-year-old CMV driver presents for his physical qualification examination and discloses that he used cocaine recreationally three months ago but has since stopped. His urine drug screen is negative. According to FMCSA regulations, is there a mandatory waiting period before the ME can issue certification?

A 52-year-old CMV driver on methadone maintenance for chronic pain presents with a letter from his prescribing physician confirming familiarity with his medical history and advising the drug will not impair safe CMV operation. During the physical examination, the ME observes significant sedation and slowed reflexes. What is the most appropriate action?

A 39-year-old CMV driver reports taking Suboxone (buprenorphine/naloxone) for opioid use disorder. He also takes gabapentin for neuropathic pain and reports occasional drowsiness during the day. His Suboxone prescriber has provided documentation meeting the prescription exception requirements. How should the ME approach this situation?

The demands of commercial driving may alter the effects of scheduled medications in several ways. According to the FMCSA handbook, which of the following factors can complicate adherence to prescribed dosing intervals for CMV drivers?

Questions 31 and 32 on the Medical Examination Report Form (MCSA-5875) relate to illegal drug use. According to FMCSA guidance, what is the purpose of these questions?

A 58-year-old CMV driver is taking oxycodone (Schedule II), prescribed by his primary care physician for chronic back pain. His wife’s physician, who is not familiar with the driver’s medical history, also prescribed zolpidem for insomnia. The driver presents both prescriptions during the physical qualification examination. The ME must determine whether the prescription exception under 49 CFR 391.41(b)(12)(ii) is met for each medication. Which of the following is correct?

A CMV driver discloses that he is currently prescribed methadone by a licensed physician for chronic pain management. The prescribing physician confirms familiarity with the driver’s medical history and has advised that methadone will not adversely affect his ability to safely operate a CMV. What is the correct action for the ME?

Why can a medical examiner never physically qualify a CMV driver who uses a Schedule I substance, even if the substance is legal in the driver’s state of residence?

A CMV driver discloses that he was treated for heroin addiction 3 years ago and has been in a medication-assisted treatment program using methadone (Schedule II) for the past 2 years. His prescribing physician has provided documentation that the methadone treatment is stable and will not adversely affect his ability to safely operate a CMV. The driver has no signs of impairment at the examination. What is the correct certification approach?

A CMV driver reports using a CBD oil product purchased from a retail store. The product label states it contains less than 0.3% THC by dry weight. The driver also reports having a medical marijuana card from a state where marijuana is legal for medicinal use but states he stopped using marijuana 6 months ago. The ME suspects possible undisclosed marijuana use. What is the most appropriate action?

A driver presents for a physical qualification examination and reports a prior clinical diagnosis of alcoholism from 4 years ago. He completed a treatment program and has been in remission for 3 years. During the physical examination, the ME notes spider angiomata on the abdomen and mild hepatomegaly. The driver reports he has not consumed alcohol in 3 years. What should the ME consider when making the certification determination?

Under 49 CFR 391.41(b)(12), which of the following is true regarding a CMV driver who uses a Schedule I controlled substance?

According to the regulations, what does the physical qualification standard state about a CMV driver’s use of alcohol?

A 45-year-old driver reports a history of alcohol dependence but states he has been sober for 3 years and attends regular counseling. What should the ME consider when making a certification decision?

A driver reports using methadone as prescribed by a pain management specialist. How should the ME handle this situation?

A driver taking buprenorphine (Suboxone) for opioid use disorder maintenance therapy presents for a physical qualification examination. What is the correct approach?

A driver discloses taking oxycodone for chronic back pain. The prescribing physician states the driver is stable on the medication. What additional factors should the ME consider?

Is DOT-regulated drug and alcohol testing part of the physical qualification examination?

A driver reports using medical marijuana in a state where it is legal. The driver has a valid state-issued medical marijuana card. How should the ME address this?

During a physical qualification examination, the ME suspects a driver may be under the influence of a controlled substance. What is the appropriate action?

Under federal regulations, what is the exception that allows a driver to use a Schedule II through V controlled substance and still be physically qualified?

A driver reports drinking 2 to 3 beers most evenings but denies any history of alcohol-related problems. The ME notes mild hepatomegaly on physical examination. What should the ME consider?

A driver states that DOT drug and alcohol testing was already completed by the employer. Does this satisfy the ME’s responsibilities during the physical qualification examination?

A driver who was previously denied certification due to active substance abuse returns after completing treatment. What must the ME determine before certifying the driver?

A driver uses amphetamine-based medication prescribed for ADHD. The treating physician confirms the driver is stable and functioning well. What should the ME evaluate?

According to 49 CFR 391.41(b)(13), which of the following conditions disqualifies a driver from operating a CMV?

During the health history portion of the examination, a driver discloses past recreational use of cocaine but states it was years ago. How should the ME proceed?